Secondary Prevention

The prevention of recurrences or exacerbations of a disease or complications of its therapy.

Also Known As:

Disease Prevention, Secondary; Early Therapy; Relapse Prevention; Secondary Disease Prevention; Disease Preventions, Secondary; Early Therapies; Prevention, Relapse; Prevention, Secondary; Prevention, Secondary Disease; Preventions, Relapse; Preventions, Secondary; Preventions, Secondary Disease; Relapse Preventions; Secondary Disease Preventions; Secondary Preventions; Therapies, Early; Therapy, Early

Networked: 15424 relevant articles (1288 outcomes, 3021 trials/studies)

Relationship Network

Therapy Context: Research Results

Experts

1.	Bhatt, Deepak L: 47 articles (01/2022 - 05/2003)
2.	Lip, Gregory Y H: 41 articles (04/2022 - 05/2003)
3.	Benavente, Oscar R: 38 articles (12/2021 - 02/2007)
4.	Wang, Yongjun: 35 articles (09/2022 - 01/2006)
5.	Rothwell, Peter M: 33 articles (01/2022 - 01/2003)
6.	McClure, Leslie A: 32 articles (12/2021 - 02/2007)
7.	Diener, Hans-Christoph: 30 articles (01/2022 - 09/2001)
8.	Bonaca, Marc P: 28 articles (01/2022 - 09/2009)
9.	Hart, Robert G: 27 articles (12/2020 - 04/2004)
10.	Redfern, Julie: 26 articles (10/2022 - 06/2006)

Related Diseases

1.	Stroke (Strokes) 08/01/2010 - "The recent extension of the time window for systemic thrombolysis to 4.5 hours must not result in any delays of diagnosis and treatment initiation! Stroke units with facilities for early etiological workup with according secondary prevention measures, for prevention and treatment of complications, and for early rehabilitation have been shown to yield the best outcome for all stroke victims." 10/01/2019 - "Findings indicate that implementation of this novel cardiac rehabilitation programme, and of a trial to evaluate its effectiveness, is feasible, with potential for clinically important benefits and improved secondary prevention after TIA or 'minor' stroke." 01/01/2023 - "The system-integrated and technology-enabled model of care (SINEMA) intervention, a primary care-based and technology-enabled model of care, has been proven effective in strengthening the secondary prevention of stroke in rural China. " 04/08/2021 - "A correlation found between ischemic lesion location and vascular pathology with post-stroke consequences in pediatric AIS may be important information and helpful in choosing proper early therapy. " 01/01/2019 - "Despite secondary prevention strategies with proven efficacy, recurrent stroke rates remain high, particularly in racial/ethnic minority populations who are disproportionately affected by stroke. "
2.	Cardiovascular Diseases (Cardiovascular Disease) 01/01/2023 - "To examine improvement in the use of optimal medical therapy (OMT) for secondary prevention in patients with atherosclerotic cardiovascular disease (ASCVD) and diabetes. " 10/01/2003 - "Primary and secondary prevention studies have revealed a significant reduction of risk for cardiovascular diseases. " 01/01/2021 - "After six months of follow-up, BALANCE Program led to a significant reduction on BMI and waist circumference in individuals in secondary prevention for cardiovascular disease. " 01/01/2019 - "It is currently indicated for use in those with rheumatologic disorders due to its anti-inflammatory properties, and was recently shown to be beneficial for the secondary prevention of cardiovascular disease (CVD). " 01/01/2013 - "This Cochrane Review has been superseded by a review entitled Vegan dietary pattern for the primary and secondary prevention of cardiovascular diseases (https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013501.pub2/full) https://pubmed.ncbi.nlm.nih.gov/33629376/ There is increasing evidence that high consumption of fruit and vegetables is beneficial for cardiovascular disease (CVD) prevention. "
3.	Myocardial Infarction 02/15/1992 - "For reducing rates of fatal and non-fatal acute myocardial infarction a multifaceted strategy of primary and secondary prevention and improved acute care is found most effective. " 01/01/1992 - "Thus, beta-blockers are highly effective agents in the secondary prevention of myocardial infarction and are moderately effective in primary prevention of myocardial infarction in hypertensive patients (particularly men) under the age of 65 years." 07/01/2013 - "No trial of cardiac rehabilitation (CR) following myocardial infarction (MI) (not even the WHO European collaborative) demonstrates significant reduction of mortality, as do trials of secondary prevention. " 01/01/2018 - "Our data show suboptimal long-term adherence to secondary prevention treatment in this high-risk population of survivors of myocardial infarction, which seems to be improved in patients exposed to a cardiac rehabilitation program." 01/01/2013 - "Despite the significant benefits of secondary prevention (SP) medication after acute myocardial infarction (MI), evidence suggests that these medications are neither consistently prescribed nor appropriately adhered to by patients. "
4.	Coronary Disease (Coronary Heart Disease) 04/19/2008 - "Most evidence on the efficacy of intensive preventive programs of secondary prevention of coronary diseases comes from Anglo-Saxon countries and effectiveness remains controversial. " 11/01/2011 - "Cardiac rehabilitation (CR) is a proven effective means for secondary prevention of coronary heart disease. " 06/01/1999 - "Secondary prevention by pharmacological and non-pharmacological means is also very effective in diabetic patients with coronary heart disease, although often poorly used by patients and physicians. " 07/01/2005 - "A randomised trial of nurse-led secondary prevention clinics for coronary heart disease resulted in improved secondary prevention and significantly lowered all-cause mortality at 4-year follow-up. " 07/01/2019 - "Preventive catheter ablation of VT in patients with coronary heart disease at the time of secondary prevention ICD implantation results in a significant reduction of appropriate ICD shocks and any appropriate ICD therapy compared with patients without or with deferred VT ablation. "
5.	Ischemic Stroke 01/01/2012 - "Antiplatelet therapy has proven efficacy in the secondary prevention of recurrent non-cardioembolic ischaemic stroke. " 06/01/2011 - "Percutaneous PFO closure appears to be effective for secondary prevention of cryptogenic stroke in younger patients but seems to be related with less beneficial outcome in elderly. " 10/01/2021 - "Recent trials have shown that transcatheter PFO closure is superior to medical treatment in the secondary prevention of ischaemic stroke. " 03/01/2001 - "There is considerable evidence from randomized trials that antiplatelet therapy is effective in the secondary prevention of ischemic strokes. " 01/01/1999 - "This study clearly demonstrates that combination therapy with DP and ASA is superior to either agent used alone in the secondary prevention of ischemic stroke, irrespective of the age of the patient."

Related Drugs and Biologics

1.	Aspirin (Acetylsalicylic Acid)
2.	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)
3.	Lipids
4.	Clopidogrel (Plavix)
5.	Platelet Aggregation Inhibitors (Antiplatelet Drugs)
6.	Warfarin (Coumadin)
7.	Anticoagulants
8.	Cholesterol
9.	Dipyridamole (Persantine)
10.	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)

Related Therapies and Procedures

1.	Therapeutics
2.	Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
3.	Cardiac Rehabilitation
4.	Drug Therapy (Chemotherapy)
5.	Hormone Replacement Therapy (Therapy, Hormone Replacement)